Among proteins enriched for interactions regulating these processes and associated with known CCM markers, we found LGALS3BP (Lectin galactoside-binding soluble 3 binding protein), an important clinical tumor biomarker35. This evidence concerns the gene LGALS3BP and neoplasm.